Vertex Pharmaceuticals Incorporated: Acute Pain trials
The registry lists 10 Acute Pain studies with Vertex Pharmaceuticals Incorporated as lead sponsor. 0 are open to participants now and 6 have results posted.
Phase 1 1Phase 2 5Phase 3 2Phase 4 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an AbdominoplastyCompletedNCT05558410Phase 3Results posted
- Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a BunionectomyCompletedNCT05553366Phase 3Results posted
- A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an AbdominoplastyCompletedNCT05034952Phase 2Results posted
- A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After a BunionectomyCompletedNCT04977336Phase 2Results posted
- A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following BunionectomyCompletedNCT03764072Phase 2Results posted
- A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following BunionectomyCompletedNCT03206749Phase 2Results posted
- A Single-Arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Aesthetic or Reconstructive SurgeriesCompletedNCT06887972Phase 4
- A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected SurgeriesCompletedNCT06887959Phase 4
- A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a BunionectomyCompletedNCT06619847Phase 2
- A Phase 1 Dose Escalation Study of Oral VX-708 in Healthy ParticipantsCompletedNCT05347394Phase 1